Is a Blood Pressure Target of <130/80 mm Hg Still Appropriate for High-Risk Patients?

被引：11

作者：

Chalmers, John ^{[1
,2
]}

机构：

[1] Univ Sydney, George Inst Global Hlth, Camperdown, NSW 2050, Australia

[2] Royal Prince Alfred Hosp, Camperdown, NSW 2050, Australia

来源：

CIRCULATION | 2011年 / 124卷 / 16期

关键词：

Editorials; blood pressure; clinical trials; coronary heart disease; renal; stroke; ONGOING TELMISARTAN; J-CURVE; DISEASE; METAANALYSIS; COMBINATION; PREVENTION; BENEFITS;

D O I：

10.1161/CIRCULATIONAHA.111.057091

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1700 / 1702

页数：3

共 19 条

[1] 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension
Afridi, I
Canny, J
Yao, CH
Christensen, B
Cooper, RS
Kadiri, S
Hill, S
Kaplan, N
Kuschnir, E
Lexchin, J
Mendis, S
Poulter, N
Psaty, BM
Rahn, KH
Sheps, SG
Whitworth, J
Yach, D
Bengoa, R
Ramsay, L
Kaplan, N
Mendis, S
Poulter, N
Whitworth, J
[J]. JOURNAL OF HYPERTENSION, 2003, 21 (11) : 1983 - 1992
[2] Alderman M, 1997, J HYPERTENS, V15, P105
[3] CHOBANIAN AV, 2003, JAMA-J AM MED ASSOC, V289, P2560, DOI DOI 10.1161/01.HYP.0000107251.49515.C2
[4] Tight Blood Pressure Control and Cardiovascular Outcomes Among Hypertensive Patients With Diabetes and Coronary Artery Disease
Cooper-DeHoff, Rhonda M.
Gong, Yan
Handberg, Eileen M.
Bavry, Anthony A.
Denardo, Scott J.
Bakris, George L.
Pepine, Carl J.
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 304 (01): : 61 - 68
[5] CRUICKSHANK JM, 1987, LANCET, V1, P581
[6] Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus
Cushman, William C.
Evans, Gregory W.
Byington, Robert P.
Goff, David C., Jr.
Grimm, Richard H., Jr.
Cutler, Jeffrey A.
Simons-Morton, Denise G.
Basile, Jan N.
Corson, Marshall A.
Probstfield, Jeffrey L.
Katz, Lois
Peterson, Kevin A.
Friedewald, William T.
Buse, John B.
Bigger, J. Thomas
Gerstein, Hertzel C.
Ismail-Beigi, Faramarz
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 2010, 362 (17) : 1575 - 1585
[7] A likely explanation for the J-curve of blood pressure cardiovascular risk
Kannel, WB
Wilson, PWF
Nam, BH
D'Agostino, RB
Li, J
[J]. AMERICAN JOURNAL OF CARDIOLOGY, 2004, 94 (03) : 380 - 384
[8] Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies
Law, M. R.
Morris, J. K.
Wald, N. J.
[J]. BMJ-BRITISH MEDICAL JOURNAL, 2009, 338 : 1245
[9] Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8
[10] BLOOD-PRESSURE, STROKE, AND CORONARY HEART-DISEASE .1. PROLONGED DIFFERENCES IN BLOOD-PRESSURE - PROSPECTIVE OBSERVATIONAL STUDIES CORRECTED FOR THE REGRESSION DILUTION BIAS
MACMAHON, S
PETO, R
CUTLER, J
COLLINS, R
SORLIE, P
NEATON, J
ABBOTT, R
GODWIN, J
DYER, A
STAMLER, J
[J]. LANCET, 1990, 335 (8692) : 765 - 774

← 1 2 →

Is a Blood Pressure Target of &lt;130/80 mm Hg Still Appropriate for High-Risk Patients?

Is a Blood Pressure Target of <130/80 mm Hg Still Appropriate for High-Risk Patients?